Mycotechnology and IFF join forces in Europe to create better food system
Mycotechnology, a company using mycelia, the roots of mushrooms, and IFF have formed a partnership…
Mycotechnology, a company using mycelia, the roots of mushrooms, and IFF have formed a partnership…
BioPharma Dynamics have expanded their portfolio for the cell and gene therapy market to offer…
Aptamer Group developer of Optimer binders that enable development in the life sciences industry has…
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus…
The World Health Organisation (WHO) said today (November 28) it will begin using mpox, as…
STORM Therapeutics Ltd, announced today that the first patient in a phase 1 study had…
C4X Discovery Holdings plc has signed an exclusive worldwide licensing agreement with AstraZeneca. It is worth…
Slovenian-based Sartorius BIA Separations (BIA), a bio-chromatography company, and Australia's Exopharm Ltd., a company working…
OSE Immunotherapeutics SA has announced the publication of data in the peer-reviewed journal Science Advances…
Clinical-stage pharmaceutical company, Khondrion, discovering and developing therapies targeting primary mitochondrial diseases announced yesterday (November…
An impressive crowd gathered at Chiesi Pharmaceutical Group yesterday (November 21) to mark the much-anticipated…
A new anti-virulence therapy, RESP-X, treating Pseudomonas aeruginosa (Pa) infections in non-cystic fibrosis bronchiectasis (NCFB)…